Livzon Pharmaceutical Group Inc Cash Flow-to-Debt Ratio
Livzon Pharmaceutical Group Inc cash flow-to-debt ratio. Livzon Pharmaceutical Group Inc (000513) has a Cash Flow-to-Debt Ratio of 0.08x as of December 2025, meaning its operating cash flow of CN¥625.70 Million could theoretically repay 0% of its total liabilities (CN¥8.20 Billion) in one year. Check Livzon Pharmaceutical Group Inc (000513) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Livzon Pharmaceutical Group Inc (1998–2025)
Cash flow-to-debt ratio of Livzon Pharmaceutical Group Inc from 1998 to 2025. Historical debt coverage capacity for Livzon Pharmaceutical Group Inc across 28 annual periods. Check cash flow quality index of Livzon Pharmaceutical Group Inc to evaluate the quality of earnings relative to operating cash generation.
Livzon Pharmaceutical Group Inc Cash Flow-to-Debt Ratio by Year (1998–2025)
Livzon Pharmaceutical Group Inc cash flow-to-debt ratio by year from 1998 to 2025. Year-by-year debt coverage analysis for Livzon Pharmaceutical Group Inc. For the full cash flow conversion analysis, see 000513 cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.39x | CN¥3.18 Billion | CN¥8.20 Billion | ▲ +24.3% |
| 2024 | 0.31x | CN¥2.98 Billion | CN¥9.55 Billion | ▼ -1.3% |
| 2023 | 0.32x | CN¥3.25 Billion | CN¥10.28 Billion | ▲ +13.2% |
| 2022 | 0.28x | CN¥2.77 Billion | CN¥9.93 Billion | ▲ +18.3% |
| 2021 | 0.24x | CN¥1.90 Billion | CN¥8.06 Billion | ▼ -24.1% |
| 2020 | 0.31x | CN¥2.16 Billion | CN¥6.95 Billion | ▲ +0.3% |
| 2019 | 0.31x | CN¥1.77 Billion | CN¥5.70 Billion | ▲ +39.1% |
| 2018 | 0.22x | CN¥1.27 Billion | CN¥5.69 Billion | ▼ -21.0% |
| 2017 | 0.28x | CN¥1.32 Billion | CN¥4.66 Billion | ▼ -24.5% |
| 2016 | 0.37x | CN¥1.28 Billion | CN¥3.42 Billion | ▲ +31.6% |
| 2015 | 0.28x | CN¥927.79 Million | CN¥3.27 Billion | ▲ +27.4% |
| 2014 | 0.22x | CN¥717.39 Million | CN¥3.22 Billion | ▲ +50.0% |
| 2013 | 0.15x | CN¥439.99 Million | CN¥2.96 Billion | ▼ -38.6% |
| 2012 | 0.24x | CN¥593.96 Million | CN¥2.45 Billion | ▼ -45.6% |
| 2011 | 0.45x | CN¥708.20 Million | CN¥1.59 Billion | ▼ -28.1% |
| 2010 | 0.62x | CN¥633.30 Million | CN¥1.02 Billion | ▲ +12.5% |
| 2009 | 0.55x | CN¥494.88 Million | CN¥898.92 Million | ▲ +73.7% |
| 2008 | 0.32x | CN¥345.18 Million | CN¥1.09 Billion | ▲ +21.7% |
| 2007 | 0.26x | CN¥248.55 Million | CN¥954.80 Million | ▲ +23.7% |
| 2006 | 0.21x | CN¥226.46 Million | CN¥1.08 Billion | ▲ +20.8% |
| 2005 | 0.17x | CN¥161.07 Million | CN¥925.20 Million | ▼ -1.2% |
| 2004 | 0.18x | CN¥181.46 Million | CN¥1.03 Billion | ▼ -43.9% |
| 2003 | 0.31x | CN¥300.01 Million | CN¥954.70 Million | ▲ +6.9% |
| 2002 | 0.29x | CN¥213.65 Million | CN¥727.05 Million | ▲ +21.1% |
| 2001 | 0.24x | CN¥155.15 Million | CN¥639.37 Million | ▲ +266.2% |
| 2000 | 0.07x | CN¥38.52 Million | CN¥581.24 Million | ▼ -84.3% |
| 1999 | 0.42x | CN¥246.23 Million | CN¥583.95 Million | ▲ +1182.7% |
| 1998 | -0.04x | CN¥-18.21 Million | CN¥467.61 Million | — |